Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder (Q37692558)
Jump to navigation
Jump to search
scientific article published on May 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder |
scientific article published on May 2014 |
Statements
1 reference
Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder (English)
1 reference
Jean-Philippe Boulenger
1 reference
Henrik Loft
1 reference
Christina Kurre Olsen
1 reference
1 May 2014
1 reference
1 reference
138-149
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference